文献速递白内障与屈光手术

衍射三焦点与单焦点人工晶状体视觉及患者报告结局比较

Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens.
PubMed 文献 · Ophthalmology · 2020-09-28

结果显示TFNT00在6个月时近距和中距矫正视力优于单焦点,远距非劣效,脱镜率更高,但光晕等视觉干扰更常见,严重困扰者不足5%。

要点

  • TFNT00组6个月时光学单眼近距矫正视力比SN60AT组高0.42 logMAR(P<0.001)。
  • TFNT00组中距矫正视力比SN60AT组高0.26 logMAR(P<0.001),远距最佳矫正视力非劣效。
  • TFNT00组80.5%患者完全不戴镜,SN60AT组为8.2%,但TFNT00组星芒、光晕和眩光更常见。

核心结论

  • TFNT00三焦点人工晶状体在6个月时提供优于单焦点SN60AT的近距和中距矫正视力,远距最佳矫正视力非劣效,脱镜率高,严重视觉干扰困扰者不足5%。

主要发现

  • TFNT00组与SN60AT组6个月时光学单眼最佳矫正远视力(4米)非劣效(95%置信上限差值<0.1 logMAR界值)。
  • TFNT00组6个月时光学单眼距离矫正近视力(40厘米)比SN60AT组高0.42 logMAR(P<0.001),距离矫正中视力(66厘米)高0.26 logMAR(P<0.001)。
  • TFNT00组完全不戴镜比例为80.5%,SN60AT组为8.2%。
  • TFNT00组最常评为严重的视觉症状为星芒、光晕和眩光,但6个月时非常困扰者不足5%。

关键数值与推荐

  • 主要疗效终点为术后6个月光学单眼最佳矫正远视力(4米)和距离矫正近视力(40厘米)。
  • 远视力非劣效界值为95%置信上限差值<0.1 logMAR。
  • TFNT00组双眼视力在+0.5 D至-2.5 D范围内达20/25或更好。

临床怎么用

  • 对希望减少眼镜依赖的白内障患者,TFNT00可提供更好的近距和中距视力,但需告知星芒、光晕和眩光等视觉干扰风险,多数患者不因此严重困扰。

局限性

  • 为非随机设计,患者自行选择人工晶状体,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effectiveness and safety of a trifocal intraocular lens (IOL), the TFNT00 (Alcon, Fort Worth, TX), versus a monofocal IOL, the SN60AT (Alcon). DESIGN: Food and Drug Administration-approved, prospective, multicenter, nonrandomized, parallel-group, assessor-masked, confirmatory trial. PARTICIPANTS: Patients enrolled were 22 years of age or older with a diagnosis of bilateral cataract with planned removal by phacoemulsification with a clear corneal incision. METHODS: Consented participants selected their preferred IOL, which was implanted sequentially into each eye of patients meeting eligibility criteria. MAIN OUTCOME MEASURES: The coprimary effectiveness outcomes were mean photopic monocular best-corrected distance visual acuity (BCDVA; 4 m) and distance-corrected near visual acuity (DCNVA; 40 cm) at 6 months after surgery. Secondary effectiveness outcomes included mean monocular distance-corrected intermediate visual acuity (DCIVA; 66 cm) and proportion of participants responding "never" to question 1 of the Intraocular Lens Satisfaction questionnaire (regarding frequency of spectacle use in the past 7 days). Safety outcomes included frequency of "severe" and "most bothersome" visual disturbances. RESULTS: Two hundred forty-three patients underwent cataract surgery with bilateral implantation of the TFNT00 (n = 129) or SN60AT (n = 114) and were followed up for 6 months. Noninferiority of TFNT00 to SN60AT in mean photopic monocular BCDVA (95% upper confidence limit of the difference was <0.1 logarithm of the minimum angle of resolution [logMAR] margin), and superiority in mean photopic monocular DCNVA (difference of 0.42 logMAR; P < 0.001) and DCIVA (difference of 0.26 logMAR; P < 0.001) were demonstrated. The proportion of patients never requiring glasses overall was superior for TFNT00 versus SN60AT (80.5% and 8.2%, respectively). Starbursts, halos, and glare were the most frequently rated severe symptoms with TFNT00; however, less than 5% of patients were very bothered at month 6. CONCLUSIONS: The TFNT00 exhibited superior monocular DCNVA and DCIVA to a spherical monofocal IOL, with comparable monocular BCDVA. Binocular visual acuity was 20/25 or better for distance to near (+0.5 D to -2.5 D), resulting in high levels of spectacle independence. Less than 5% of patients were very bothered by the photic visual disturbances associated with the TFNT00 at 6 months after surgery.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Modi S, Lehmann R, Maxwell A, et al. Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens. Ophthalmology. 2020. PMID: 33004211. doi:10.1016/j.ophtha.2020.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。